Home › Funds › Logos Global Management LP › JBIO

Logos Global Management LP position in JBIO

JADE BIOSCIENCES INC · Health Care

Logos Global Management LP reported holding 1,125,000 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$25.0M, representing 1.08% of its reported portfolio and ranking #31 among its reported holdings. Logos Global Management LP has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)1.12M sh
Reported value held$25.00M
Portfolio Weight1.08%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's JBIO position evolved

Logos Global Management LP first disclosed a stake in JBIO in Q2 2025 at 625,000 shares (US$6.2M). The position peaked in Q2 2026 at 1,125,000 shares, worth US$25.0M. Across 5 filings, Logos Global Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,125,000 shares valued at US$25.0M — an increase of 725,000 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2025 (shares fell 9% over the following quarter), a 181% increase in Q2 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 625.00K $6.24M New
Q3 2025 625.00K $5.39M Hold
Q4 2025 395.00K $6.09M Reduce
Q1 2026 400.00K $5.62M Add
Q2 2026 1.12M $25.00M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Logos Global Management LP held JBIO?

Logos Global Management LP has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Logos Global Management LP's current position in JBIO?

As of Q2 2026, Logos Global Management LP holds 1.12M shares of JBIO (JADE BIOSCIENCES INC), valued at $25.00M, representing 1.08% of its reported portfolio and ranking #31.

Has Logos Global Management LP been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in JBIO. The position peaked in Q2 2026 at 1.12M shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.